中文版 | English

在结果中检索

HFCAS OpenIR

浏览/检索结果: 共4条，第1-4条 帮助

已选(0)清除 条数/页：   排序方式：
Analysis of the efficacy and safety of immunotherapy in advanced thymoma patients 期刊论文
CANCER MEDICINE, 2022
作者:  Hao, Yue;  Lin, Gen;  Xiang, Jing;  Wang, Wenxian;  Xu, Chunwei;  Wang, Qian;  Cai, Jing;  Zhang, Yongchang;  Song, Zhengbo
收藏  |  浏览/下载：39/0  |  提交时间：2022/12/23
efficacy  immune-related adverse events  immunotherapy  thymoma  
Treatment outcomes and prognosis of immune checkpoint inhibitors therapy in patients with advanced thymic carcinoma: A multicentre retrospective study 期刊论文
EUROPEAN JOURNAL OF CANCER, 2022, 卷号: 174
作者:  Wang, Wenxian;  Lin, Gen;  Guan, Yelan;  Zhang, Yuxin;  Xu, Chunwei;  Wang, Qian;  Wang, Dong;  Jiang, Zhansheng;  Cai, Jing;  Lou, Guangyuan;  Song, Zhengbo;  Zhang, Yongchang
收藏  |  浏览/下载：41/0  |  提交时间：2022/12/23
Thymic carcinoma  Immunotherapy  PD-1  Efficacy  Immune-related adverse events  
Image classification of immune checkpoint inhibitor-related pneumonia in lung cancer patients 期刊论文
CLINICAL IMAGING, 2022, 卷号: 86
作者:  Sun, Xiaojun;  Song, Zhengbo;  Jiang, Hongyang;  Ma, Yanqing;  Chen, Ming
收藏  |  浏览/下载：37/0  |  提交时间：2022/12/23
Immune checkpoint inhibitor (ICI)  Immune-related adverse events  

Immune checkpoint inhibitor-related & nbsp  Lung cancer  Image classification  pneumonia (ICIP)

  
Immune checkpoint inhibitor-related adverse events in lung cancer: Real-world incidence and management practices of 1905 patients in China 期刊论文
THORACIC CANCER, 2021
作者:  Shi, Yuequan;  Fang, Jian;  Zhou, Chengzhi;  Liu, Anwen;  Wang, Yan;  Meng, Qingwei;  Ding, Cuimin;  Ai, Bin;  Gu, Yangchun;  Yao, Yu;  Sun, Hong;  Guo, Hui;  Zhang, Cuiying;  Song, Xia;  Li, Junling;  Xu, Bei;  Han, Zhiqiang;  Song, Meijun;  Tang, Tingyu;  Chen, Peifeng;  Lu, Hongmin;  Shui, Yongjie;  Lou, Guangyuan;  Zhang, Dongming;  Liu, Jia;  Liu, Xiaoyan;  Liu, Xiangning;  Gao, Xiaoxing;  Zhou, Qing;  Chen, Minjiang;  Zhao, Jing;  Zhong, Wei;  Xu, Yan;  Wang, Mengzhao
收藏  |  浏览/下载：90/0  |  提交时间：2022/01/25
advanced lung cancer  immune checkpoint inhibitors  immune-related adverse events  real-world data